Chitogenx Stock Debt To Equity
| CHNXF Stock | USD 0.01 0.0001 2.00% |
ChitogenX fundamentals help investors to digest information that contributes to ChitogenX's financial success or failures. It also enables traders to predict the movement of ChitogenX OTC Stock. The fundamental analysis module provides a way to measure ChitogenX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChitogenX otc stock.
ChitogenX |
ChitogenX OTC Stock Debt To Equity Analysis
ChitogenX's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, ChitogenX has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
ChitogenX Fundamentals
| Return On Asset | -2.92 | |||
| Current Valuation | 12.49 M | |||
| Shares Outstanding | 51.04 M | |||
| Shares Owned By Insiders | 17.44 % | |||
| EBITDA | (3.72 M) | |||
| Net Income | (4.92 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 4.78 M | |||
| Current Ratio | 1.26 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (3.22 M) | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.86 M | |||
| Total Asset | 1.12 M | |||
| Z Score | -8.7 | |||
| Net Asset | 1.12 M |
About ChitogenX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChitogenX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChitogenX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChitogenX based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.